Literature DB >> 3729174

Endotracheal aminoglycosides in gram negative pneumonia. A preliminary report.

V J Sorensen, H M Horst, F N Obeid, B A Bivins.   

Abstract

Five postoperative patients with respiratory failure and gram negative pneumonia unresponsive to systemic antimicrobials were treated with endotracheally instilled aminoglycosides. Sputum cultures in four patients grew Pseudomonas aeruginosa and, in the fifth, Enterobacter cloacae. The five patients had been treated systemically for an average of 13 days (range 9 to 19 days) without improvement prior to endotracheal antibiotic administration. The gram negative organisms disappeared from the sputum cultures in all patients within an average of 4 days (range 2 to 8 days) following initiation of endotracheal antibiotics. All five patients had continued clinical improvement manifest by improved chest radiographs, improved oxygenation, and absence of the offending organisms from sputum cultures. None of the patients died from their gram negative pneumonia. This success coupled with data from other investigators suggests that endotracheal antibiotics should be considered in life-threatening gram negative pneumonias that are unresponsive to conventional systemic antimicrobials.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3729174

Source DB:  PubMed          Journal:  Am Surg        ISSN: 0003-1348            Impact factor:   0.688


  5 in total

Review 1.  Aerosolised antibacterials for the prevention and treatment of hospital-acquired pneumonia.

Authors:  G Christopher Wood; Joseph M Swanson
Journal:  Drugs       Date:  2007       Impact factor: 9.546

Review 2.  Antimicrobial agent therapy for Pseudomonas aeruginosa.

Authors:  J A Korvick; V L Yu
Journal:  Antimicrob Agents Chemother       Date:  1991-11       Impact factor: 5.191

3.  Elevated tobramycin concentrations following endotracheal administration in a premature infant.

Authors:  Amanda Howard-Thompson; Michael L Christensen
Journal:  J Pediatr Pharmacol Ther       Date:  2008-04

4.  Double-blind study of endotracheal tobramycin in the treatment of gram-negative bacterial pneumonia. The Endotracheal Tobramycin Study Group.

Authors:  R B Brown; J A Kruse; G W Counts; J A Russell; N V Christou; M L Sands
Journal:  Antimicrob Agents Chemother       Date:  1990-02       Impact factor: 5.191

Review 5.  Fundamentals of aerosol therapy in critical care.

Authors:  Jayesh Dhanani; John F Fraser; Hak-Kim Chan; Jordi Rello; Jeremy Cohen; Jason A Roberts
Journal:  Crit Care       Date:  2016-10-07       Impact factor: 9.097

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.